ATTENTION ARDT Investors: Securities Fraud Investigation Underway – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / November 29, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Ardent Health, Inc. ("Ardent Health, Inc.") (NYSE:ARDT) concerning possible violations of federal securities laws. Ardent issued a press release on November 12, 2025, announcing its financial results for the third quarter of […]

Shareholders of aTyr Pharma, Inc. (ATYR): Protect Your Rights Before December 8, 2025 – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / November 29, 2025 / If you suffered a loss on your aTyr Pharma, Inc. (NASDAQ:ATYR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/atyr-pharma-inc-lawsuit-submission-form?prid=179338&wire=1&utm_campaign=21 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Levi & Korsinsky Urges Skye Bioscience, Inc. (SKYE) Shareholders to Act Before Lead Plaintiff Deadline January 16, 2026

NEW YORK, NY / ACCESS Newswire / November 29, 2025 / If you suffered a loss on your Skye Bioscience, Inc. (NASDAQ:SKYE) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/skye-bioscience-inc-lawsuit-submission-form?prid=179328&wire=1&utm_campaign=19 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

January 5, 2026 Deadline Approaching: Join Class Action Against Inspire Medical Systems, Inc. (INSP) – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / November 29, 2025 / If you suffered a loss on your Inspire Medical Systems, Inc. (NYSE:INSP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/inspire-medical-systems-inc-lawsuit-submission-form?prid=179330&wire=1&utm_campaign=30 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

Pomerantz LLP Highlights Legal Filing Against Telix Pharmaceuticals Limited – TLX

NEW YORK CITY, NY / ACCESS Newswire / November 29, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Telix Pharmaceuticals Limited ("Telix" or the "Company") (NASDAQ:TLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

Pomerantz LLP Initiates Class Action Lawsuit Against DexCom, Inc. – DXCM

NEW YORK CITY, NY / ACCESS Newswire / November 29, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against DexCom, Inc. ("DexCom" or the "Company") (NASDAQ:DXCM) and certain officers.�� The class action, filed in the United States District Court for the Southern District of New York, and docketed under 25-cv-08912,

Pomerantz LLP Issues Important Reminder to Investors in INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in James Hardie Industries plc of Class Action Lawsuit and Upcoming Deadlines – JHX of Class Action Filing – JHX

NEW YORK CITY, NY / ACCESS Newswire / November 29, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against James Hardie Industries plc ("James Hardie" or the "Company") (NYSE:JHX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by

Pomerantz LLP Issues Important Reminder to Synopsys, Inc. Shareholders – SNPS

NEW YORK CITY, NY / ACCESS Newswire / November 29, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Synopsys, Inc. ("Synopsys" or the "Company") (NASDAQ:SNPS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

Scroll to Top